Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Canopy Growth's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $339.4 Mil. Canopy Growth's Total Assets for the quarter that ended in Mar. 2025 was $639.2 Mil.
Therefore, Canopy Growth's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.53.
The historical rank and industry rank for Canopy Growth's Equity-to-Asset or its related term are showing as below:
CGC'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31 Med: 0.68 Max: 0.91
Current: 0.53
During the past 13 years, the highest Equity to Asset Ratio of Canopy Growth was 0.91. The lowest was 0.31. And the median was 0.68.
CGC's Equity-to-Asset is ranked worse than 58.43% of 1020
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs CGC: 0.53
Canopy Growth Equity-to-Asset Historical Data
The historical data trend for Canopy Growth's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Canopy Growth's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canopy Growth's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Canopy Growth's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Canopy Growth's Equity to Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Canopy Growth Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Canopy Growth's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CGC has been successfully added to your 